GPGPeptides
  1. Home
  2. Shop
  3. GHRH & GHRP
  4. Ipamorelin 10 mg

GHRP

Ipamorelin 10 mg

€33.90

incl. VAT, plus shipping

Pre-order

Pre-order: delivery may take up to 18 working days. This notice is repeated in the basket and at checkout.

10 mg

Certificate of analysis pending Lab certificates

Research use only · Shipping within the EU

SKU: GP-0004

Form
Lyophilized powder
Minimum purity
≥99%
Analytics
HPLC / MS

Ipamorelin is a synthetic pentapeptide of the GHRP family, classed in the literature as an agonist at the ghrelin receptor (GHS-R1a). For in-vitro research only.

Specifications

FormLyophilized powder
DatabasePubChem
Minimum purity≥99%
Test methodsHPLC / MS
Unit10 mg
CategoryGHRH & GHRP
SKUGP-0004

Product information

Quick profile

  • Selective GHRP (pentapeptide)
  • Low off-target activity in studies
  • ≥99% purity

Guide · CJC-1295 and Ipamorelin: structure, analytics and handling in research →

About Ipamorelin

What is Ipamorelin?

Ipamorelin is a synthetic pentapeptide from the class of growth-hormone-releasing peptides (GHRP). It is described as a ghrelin mimetic and classed as an agonist at the ghrelin receptor, which the literature also calls the GH secretagogue receptor (GHS-R1a). It was identified in a series of compounds that lack the central Ala-Trp dipeptide of GHRP-1. Databases also list the research code NNC 26-0161 and the salt name ipamorelin acetate.

Structure and key data

With five residues, Ipamorelin is the shortest peptide in the GH category. Three of its five building blocks do not occur in this form in natural proteins:

  • Sequence: Aib-His-D-2Nal-D-Phe-Lys-NH2
  • Aib: 2-aminoisobutyric acid (2-methylalanine) at the N-terminus
  • D-2Nal: 3-(2-naphthyl)-D-alanine with an aromatic naphthyl side chain
  • D-Phe: D-phenylalanine
  • C-terminus: lysinamide
  • Molecular formula and mass: C38H49N9O5, 711.9 g/mol (free base)
  • CAS number: 170851-70-4, PubChem CID 9831659

Classification: Ipamorelin and related peptides

Research on the GH axis distinguishes between two receptor pathways. GHRH analogues such as CJC-1295 (No DAC) and Tesamorelin are derived from the sequence of growth-hormone-releasing hormone and are assigned to the GHRH receptor. Ipamorelin shares nothing with this sequence and is assigned to the ghrelin receptor, whose endogenous ligand is the peptide ghrelin. The GHRP group also includes GHRP-1, GHRP-2 and GHRP-6, which are not part of the range. The CJC-1295 + Ipamorelin blend brings both peptide families together in a single vial.

Research context

Ipamorelin is studied as a GHS-R1a agonist in research on the secretion of growth hormone from the pituitary. Its initial preclinical characterisation was carried out on primary rat pituitary cells and in animal models. A central question was selectivity: the studies examined to what extent other pituitary hormones such as ACTH are involved in addition to growth hormone. This characterisation places the molecule within the GHRP class and is not a statement about effects.

Analytics at GPeptides

In regular external testing by HPLC and mass spectrometry, such a small molecule gives a readily assignable mass spectrum: the singly protonated ion [M+H]+ is expected at a calculated m/z 712.4 (monoisotopic), and the doubly charged ion may also appear at about m/z 356.7. Deletion sequences lacking one building block are lighter by the mass of that residue and therefore stand out. Stereoisomers are a different matter: a variant with L- instead of D-phenylalanine would have the same mass, so chromatographic separation is more informative here. The available certificates of analysis (COA) are arranged by product in the lab area; without a published certificate, the product is considered “pending”. What to look out for when reading a certificate is explained in the guide to reading a certificate of analysis.

Storage and research use

Research Use Only. All products are intended exclusively for scientific in-vitro research and not for human or animal use.

UseResearch only (in-vitro)
StorageDry & cool · −20 °C long-term

Certificate of Analysis (COA)

Certificate of analysis pending

The certificate for this product will be published in the lab section as soon as it is available.

Frequently asked questions

Which receptor is Ipamorelin assigned to?

Ipamorelin is regarded as an agonist at the ghrelin receptor, also called the GH secretagogue receptor or GHS-R1a. This distinguishes it from GHRH analogues such as CJC-1295 (No DAC) and Tesamorelin, which are assigned to the GHRH receptor.

Which non-proteinogenic building blocks does Ipamorelin contain?

The sequence Aib-His-D-2Nal-D-Phe-Lys-NH2 contains 2-aminoisobutyric acid (Aib), 3-(2-naphthyl)-D-alanine and D-phenylalanine. Only histidine and lysine are present in the natural L-form; the C-terminus is an amide.

Under which other names is Ipamorelin known?

Databases also list Ipamorelin under the research code NNC 26-0161 (NNC-26-0161), as ipamorelin acetate and in the sequence notation Aib-His-D-2-Nal-D-Phe-Lys-NH2. All of these names denote the same pentapeptide with CAS number 170851-70-4.

How does Ipamorelin differ from the CJC-1295 + Ipamorelin blend?

The single product contains only Ipamorelin, with a fill of 10 mg. In the blend, Ipamorelin is present together with the GHRH analogue CJC-1295 in one vial, with a total amount of 10 mg.